Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 18/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 17/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 15/20 | 1.00 |
| ▸ | PPARD | Q03181 | 4/20 | 0.76 |
| ▸ | PPARG | P37231 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13318025 | 1.00 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL24414330 | 1.00 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL3323143 | 1.00 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL30513698 | 1.00 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL29700194 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL21704479 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL13317693 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL24414338 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL3328015 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG | |
| SCHEMBL13298743 | 0.90 | ADORA2A (1.00) | ADORA2AADORA1ADORA3PPARDPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9018371-B2 | Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient | FM THERAPEUTICS CO., LTD. (KR) | 2015-04-28 | — | — | US | disclosed |
| US-9018371-B2 | Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient | FM THERAPEUTICS CO., LTD. (KR) | 2015-04-28 | — | — | US | disclosed |
| US-20100137577-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FUTURE MEDICINE CO., LTD. (KR) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137577-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | ADORA3, ADORA2A, ADORA1 | ADORA2A 2/4885ADORA1 3/4885ADORA3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.